Skeletal muscle dysfunction and pulmonary rehabilitation in COPD

Clinical Pulmonary Medicine

Volumn 19, Issue 4, 2012, Pages 153-158

  Kon, Samantha S C ^a   Man, William D C ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

chronic obstructive pulmonary disease (COPD); pulmonary rehabilitation, exercise; quadriceps strength; skeletal muscle

Indexed keywords

ACETYLCYSTEINE; C REACTIVE PROTEIN; CARBOCISTEINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; INFLIXIMAB; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT GROWTH HORMONE; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ABDOMINAL WALL MUSCULATURE; AEROBIC METABOLISM; BLOOD GAS PARAMETERS; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID INDUCED MYOPATHY; DIAPHRAGM MUSCLE; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DNA POLYMORPHISM; ENDOCRINE DISEASE; ENDURANCE TRAINING; EXERCISE; GENETIC SUSCEPTIBILITY; HEALTH STATUS; HUMAN; HYPERCAPNIA; HYPOXEMIA; IMMOBILIZATION; INFLAMMATION; LOW DRUG DOSE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE EXERCISE; MUSCLE FATIGUE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; NEUROMUSCULAR ELECTRICAL STIMULATION; NONINVASIVE VENTILATION; OXIDATIVE STRESS; OXYGEN THERAPY; PULMONARY REHABILITATION; QUADRICEPS FEMORIS MUSCLE; REVIEW; UPREGULATION; WALKING AID;

EID: 84863581272     PISSN: 10680640     EISSN: 15365956     Source Type: Journal    
DOI: 10.1097/CPM.0b013e31825d59fe     Document Type: Review

References (85)

1. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4:1241-1243.
2. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153:976-980. (Pubitemid 26081648)
3. Simpson K, Killian K, McCartney N, et al. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax. 1992;47:70-75.
4. Decramer M, Gosselink R, Troosters T, et al. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10:417-423. (Pubitemid 27063862)
5. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62:115-120.
6. Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;CD003793.
7. Man WD, Soliman MG, Nikoletou D, et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax. 2003;58:665-669. (Pubitemid 36976274)
8. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:629-634. (Pubitemid 28378196)
9. Seymour JM, Ward K, Sidhu PS, et al. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax. 2009;64:418-423.
10. Serres I, Gautier V, Varray A, et al. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest. 1998;113:900-905. (Pubitemid 28216430)
11. Mador MJ, Deniz O, Aggarwal A, et al. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168:102-108. (Pubitemid 37046639)
12. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 1998;30:1467-1474. (Pubitemid 28465510)
13. Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr. 2002;76:113-119. (Pubitemid 34686556)
14. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002;19:617-625. (Pubitemid 34285157)
15. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;151(pt 1):374-377.
16. Maltais F, Simard AA, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996;153:288-293. (Pubitemid 26026864)
17. Man WD, Hopkinson NS, Harraf F, et al. Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease. Thorax. 2005;60:718-722. (Pubitemid 41297889)
18. Polkey MI, Kyroussis D, Keilty SE, et al. Exhaustive treadmill exercise does not reduce twitch transdiaphragmatic pressure in patients with COPD. Am J Respir Crit Care Med. 1995;152:959-964.
19. Levine S, Kaiser L, Leferovich J, et al. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med. 1997;337:1799-1806. (Pubitemid 28006784)
20. Levine S, Gregory C, Nguyen T, et al. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol. 2002;92:1205-1213. (Pubitemid 34670981)
21. Gea JG, Pasto M, Carmona MA, et al. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J. 2001;17:939-945. (Pubitemid 32600343)
22. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36:81-88.
23. Polkey MI, Kyroussis D, Hamnegard CH, et al. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154:1310-1317. (Pubitemid 26391174)
24. Franssen FM, Wouters EF, Schols AM. The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr. 2002;21:1-14. (Pubitemid 34257506)
25. Bossenbroek L, de Greef MH, Wempe JB, et al. Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review. COPD. 2011;8:306-319.
26. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J. 2009;33:262-272.
27. Di Francia M, Barbier D, Mege JL, et al. Tumor necrosis factoralpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;150(pt 1):1453-1455. (Pubitemid 24356667)
28. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(pt 1):1414-1418. (Pubitemid 33124019)
29. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996;51:819-824. (Pubitemid 26274084)
30. Debigare R, Marquis K, Cote CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest. 2003; 124:83-89. (Pubitemid 36851335)
31. Barreiro E, Schols AM, Polkey MI, et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax. 2008; 63:100-107. (Pubitemid 351236469)
32. Rennard SI, Fogarty C, Kelsen S, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:926-934. (Pubitemid 46684703)
33. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003;58:752-756. (Pubitemid 37094049)
34. Rahman I, Skwarska E, MacNee W. Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax. 1997;52:565-568. (Pubitemid 27298512)
35. Couillard A, Maltais F, Saey D, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:1664-1669. (Pubitemid 36760681)
36. Koechlin C, Couillard A, Simar D, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2004;169:1022-1027. (Pubitemid 38543641)
37. Crul T, Spruit MA, Gayan-Ramirez G, et al. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest. 2007;37:897-904. (Pubitemid 350029204)
38. Burdet L, de Muralt B, Schutz Y, et al. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med. 1997;156:1800-1806. (Pubitemid 28011785)
39. Schols AM, Soeters PB, Mostert R, et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995;152(pt 1):1268-1274.
40. Casaburi R, Bhasin S, Cosentino L, et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:870-878. (Pubitemid 39346482)
41. Creutzberg EC, Wouters EF, Mostert R, et al. A role for anabolicsteroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest. 2003;124:1733-1742. (Pubitemid 37433566)
42. Vianna LG, Koulouris N, Lanigan C, et al. Effect of acutehypercapnia on limb muscle contractility in humans. J Appl Physiol. 1990;69:1486-1493. (Pubitemid 20361272)
43. Decramer M, Lacquet LM, Fagard R, et al. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994;150:11-16. (Pubitemid 24209929)
44. Hopkinson NS, Man WD, Dayer MJ, et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J. 2004;24:137-142. (Pubitemid 39029079)
45. Engelen MP, Schols AM, Baken WC, et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J. 1994;7:1793-1797. (Pubitemid 24337350)
46. Lopes J, Russell DM, Whitwell J, et al. Skeletal muscle function in malnutrition. Am J Clin Nutr. 1982;36:602-610. (Pubitemid 13223049)
47. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147:1151-1156. (Pubitemid 23149871)
48. Ferreira IM, Brooks D, Lacasse Y, et al. Nutritional supplementation in stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2000;CD000998.
49. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:395-399. (Pubitemid 39214613)
50. Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr. 2008;87:385-390. (Pubitemid 351226075)
51. Man WD, Kemp P, Moxham J, et al. Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation. Clin Sci (Lond). 2009;117:281-291.
52. Vogiatzis I, Terzis G, Stratakos G, et al. Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest. 2011;140:744-752.
53. Puhan MA, Gimeno-Santos E, Scharplatz M, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;CD005305.
54. Seymour JM, Moore L, Jolley CJ, et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax. 2010;65:423-428.
55. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129:536-544.
56. Troosters T, Probst VS, Crul T, et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181:1072-1077.
57. Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis. 2011;8:89-99.
58. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial. Lancet. 2000;355:362-368.
59. Ries AL, Kaplan RM, Myers R, et al. Maintenance after pulmonary rehabilitation in chronic lung disease: A randomized trial. Am J Respir Crit Care Med. 2003;167:880-888. (Pubitemid 36801777)
60. Bernard S, Whittom F, Leblanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:896-901. (Pubitemid 29137792)
61. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: A randomized trial. Am J Med. 2000;109:207-212.
62. Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease: Deconditioning, or myopathy? Respirology. 2006;11: 681-686. (Pubitemid 44581430)
63. Casaburi R, Kukafka D, Cooper CB, et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005; 127:809-817. (Pubitemid 40775509)
64. Somfay A, Porszasz J, Lee SM, et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J. 2001;18:77-84. (Pubitemid 32717434)
65. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax. 2000;55:539-543. (Pubitemid 30398265)
66. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol. 2004;97:1637-1642. (Pubitemid 39425977)
67. Johnson JE, Gavin DJ, Adams-Dramiga S. Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD. Chest. 2002;122:464-472. (Pubitemid 35002122)
68. Appendini L, Patessio A, Zanaboni S, et al. Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;149:1069-1076. (Pubitemid 24147041)
69. Revill SM, Singh SJ, Morgan MD. Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. Respir Med. 2000;94:778-783. (Pubitemid 30628239)
70. Bianchi L, Foglio K, Porta R, et al. Lack of additional effect of adjunct of assisted ventilation to pulmonary rehabilitation in mild COPD patients. Respir Med. 2002;96:359-367.
71. Hawkins P, Johnson LC, Nikoletou D, et al. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax. 2002;57:853-859. (Pubitemid 35178608)
72. Dyer F, Flude L, Bazari F, et al. Non-invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease. BMC Pulm Med. 2011;11:58.
73. Probst VS, Troosters T, Coosemans I, et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest. 2004;126:1102-1107. (Pubitemid 39391238)
74. Vaes AW, Annegarn J, Meijer K, et al. The effects of a 'new' walking aid on exercise performance in patients with COPD: A randomized cross-over trial. Chest. 2012;141:1224-1232.
75. Vivodtzev I, Debigare R, Gagnon P, et al. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: A randomized clinical trial. Chest. 2012;141:716-725.
76. Man WD, Kemp P, Moxham J, et al. Skeletal muscle dysfunction in COPD: clinical and laboratory observations. Clin Sci (Lond). 2009;117:251-264.
77. Yeh SS, DeGuzman B, Kramer T. Reversal of COPD-Associated weight loss using the anabolic agent oxandrolone. Chest. 2002; 122:421-428. (Pubitemid 35002116)
78. Narayanan R, Mohler ML, Bohl CE, et al. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal. 2008;6:e010.
79. Steiner MC, Barton RL, Singh SJ, et al. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: A randomised controlled trial. Thorax. 2003;58:745-751. (Pubitemid 37094048)
80. van Wetering CR, Hoogendoorn M, Broekhuizen R, et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: A prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc. 2010;11:179-187.
81. Phillips SM, Glover EI, Rennie MJ. Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. J Appl Physiol. 2009;107:645-654.
82. Ande SR, Chen J, Maddika S. The ubiquitin pathway: An emerging drug target in cancer therapy. Eur J Pharmacol. 2009;625: 199-205.
83. Whittemore LA, Song K, Li X, et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun. 2003;300:965-971. (Pubitemid 36262030)
84. Bogdanovich S, Krag TO, Barton ER, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature. 2002;420:418-421. (Pubitemid 35415652)
85. Narkar VA, Downes M, Yu RT, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008;134:405-415.